The CRUK Convergence Science Centre is a partnership between 911½ñÈÕºÚÁÏ and The Institute of Cancer Research. In collaboration with our international partners we arrange a regular international seminar ‘Converging on Cancer’ on the topic of interdisciplinary cancer research. Our partners are:
- Technical University of Munich (TUM)
- Nanyang Technological University (NTU)
- Biotech Research and Innovation Centre (BRIC – University of Copenhagen)
- École Polytechnique Fédérale de Lausanne (EPFL).
In this series, we bring together speakers from across these institutions to present their research and how they use convergence science to answer cancer-related questions. This seminar will focus on Computation and AI in medical decisions.
This session will be chaired byÌýÌý(BRIC, Copenhagen).
Thursday 7th May, 10-11am BST, 11-12pm CEST, 5-6pm SGT
Speakers
Ìý(TUM)
Can AI think like an oncologist?Ìý
Lessons from agentic reasoning, body composition analysis, and predictive laboratory modelling in cancer. Recent advances in AI are moving beyond pattern recognition toward systems that can reason, plan, and act, capabilities increasingly relevant to oncology. This talk explores three converging lines of work: agentic AI systems that emulate clinical reasoning workflows, automated body composition analysis from routine imaging as a prognostic biomarker in cancer, and predictive modelling of laboratory trajectories to anticipate clinical deterioration. Together, these approaches illustrate how AI might begin to approximate – and augment – the integrative thinking of an oncologist, while highlighting the challenges and limitations that remain on the path from proof-of-concept to clinical impact.
Ìý
Ìý(911½ñÈÕºÚÁÏ)
Prognostic insights from analysing the mesoscopic architecture of human tumours
Routinely acquired human images including ultrasound, CT, MRI and PET, contain more information that we can appreciate with the naked eye. Bridging between macroscopic phenomena and mesoscopic scale, aims to provide universal patterns and new phenotypes of the entire tumour lesion(s). The talk focuses on development and application of radiomic models to understand mesoscopic tumour architecture, andÌý consequently vectors or phenotypes of prognostic relevance.
Ìý
Who can attend?
Researchers, students and anyone with an interest in convergence science relating to cancer researchÌýacross our partnered institutionsÌýare welcome to register:
- CRUK Convergence Science Centre
- 911½ñÈÕºÚÁÏ
- The Institute of Cancer Research (ICR)
- Technical University of Munich (TUM)
- Nanyang Technological University (NTU)
- Biotech Research and Innovation Centre (BRIC – University of Copenhagen)
- École Polytechnique Fédérale de Lausanne (EPFL)
- CRUK Cambridge Centre
- CRUK City of London Centre (Kings college, UCL, Barts Cancer Institute/Queen Mary University, Francis Crick)
- CRUK Manchester Centre
- CRUK Newcastle Centre
- CRUK Oxford Centre
- CRUK Scotland Centre (University of Edinburgh and University of Glasgow)
Ìý
Email icr-imperial-convergence.centre@imperial.ac.uk to receive the registration link and joining details.
Ìý